Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Comparison of Riete and Some Scores for Predicting Cancer in Unprovoked Thrombosis

Abdulrahman Al Raizah, Mohammed Ziyadah, Abdulaziz Alahmary, Nahla Wahby, Albarra Madkhali, Abdullah S. Al Saleh, Mohsen Al Zahrani, Aymen Hejazi, Ahmed Alaskar

Blood (2024) 144 (Supplement 1): 2627.

https://doi.org/10.1182/blood-2024-204655

Published: 2024

Journal Articles

Comparison of Interobserver Agreement between the 4T and the HIT Expert Probability (HEP) Scores: We Agreed Not to Agree

Abdulrahman Al Raizah, Rawan Almohamdy, Khalid Alharbi, Albarra Madkhali, Rahaf ElHussein Salem, Mohammed Alshuaibi, Abdullah S. Al Saleh, Mohsen Alzahrani, Ayman Hejazi, Hind Salama, Ahmed Alaskar

Blood (2023) 142 (Supplement 1): 5430.

https://doi.org/10.1182/blood-2023-181649

Published: 2023

Journal Articles

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Blood (2022) 140 (Supplement 1): 7599–7600.

https://doi.org/10.1182/blood-2022-158787

Published: 2022

Journal Articles

Treatments and Outcomes of Newly Diagnosed Multiple Myeloma Patients > 75 Years Old: A Retrospective Analysis

Abdullah S. Al Saleh, MBBS, Alissa Visram, MD, Harsh Parmar, MD, Angela Dispenzieri, MD, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, Rahma M Warsame, MD, Martha Q. Lacy, MD, David Dingli, MD PhD, Nelson Leung, MD, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Taxiarchis Kourelis, MD, Morie A. Gertz, MD, Ronald S. Go, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-142985

Published: 2020

Journal Articles

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

Iuliana Vaxman, MDBA, Alissa Visram, MD, Prashant Kapoor, MD, Abdullah S. Al Saleh, Shaji K. Kumar, MD, Angela Dispenzieri, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Eli Muchtar, MD, Wilson I Gonsalves, MD, S. Vincent Rajkumar, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Martha Q. Lacy, MD, Morie A. Gertz, MD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-141660

Published: 2020

Journal Articles

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

Arushi Khurana, MBBS, Matthew A Hathcock, Thomas M. Habermann, MD, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Stephen M. Ansell, MD PhD, David J. Inwards, MD, Luis F. Porrata, MD, Patrick B. Johnston, Ivana Micallef, MD, Yi Lin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142511

Published: 2020

Journal Articles

Decreased Cardiac Ejection Fraction Is Associated with Worse Survival in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

Abdullah S. Al Saleh, MBBS, Iuliana Vaxman, MDBA, Harsh Parmar, MD, Alissa Visram, MD, M Hasib Sidiqi, MBBS, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Martha Q. Lacy, MD, Rahma M Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, William J Hogan, MB, BCh, Prashant Kapoor, MD, Robert Wolf, PharmD, RPh, Angela Dispenzieri, MD, Shaji K. Kumar, MD, Morie A. Gertz, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-143076

Published: 2020

Journal Articles

Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Arushi Khurana, MBBS, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Patrick B. Johnston, Stephen M. Ansell, MD PhD, Yi Lin, MD PhD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-141058

Published: 2020

Journal Articles

Retroperitoneal Involvement of Light Chain Amyloidosis-Case Series and Literature Review

Iuliana Vaxman, MD, Alissa Visram, MD, Oren Pasvolsky, MD, Shaji K. Kumar, MD, Angela Dispenzieri, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Robert A. Kyle, MD, Prashant Kapoor, MD, Nelson Leung, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Rahma M Warsame, MD, Abdullah S. Al Saleh, Morie A. Gertz, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-138640

Published: 2020

Journal Articles

Presence of a Measurable M-Spike before Autologous Stem Cell Transplantation Is Associated with Shorter Survival in Patients with Light Chain Amyloidosis

Abdullah S. Al Saleh, MBBS, Iuliana Vaxman, MDBA, Harsh Parmar, MD, M Hasib Sidiqi, MBBS, Eli Muchtar, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Martha Q. Lacy, MD, Rahma M Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, William J Hogan, MB, BCh, Prashant Kapoor, MD, Robert Wolf, PharmD, RPh, Angela Dispenzieri, MD, Shaji K. Kumar, MD, Morie A. Gertz, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-143125

Published: 2020

Journal Articles

Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma

Abdullah S. Al Saleh, MBBS, M Hasib Sidiqi, MBBS, Morie A. Gertz, MD, Eli Muchtar, MD, Martha Q. Lacy, MD, Rahma M Warsame, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, William J Hogan, MB, BCh, Suzanne R. Hayman, MD, Prashant Kapoor, MD, Francis K. Buadi, MB, CHB, Angela Dispenzieri, MD, David Dingli, MD PhD, Shaji K. Kumar, MD

Blood (2019) 134 (Supplement_1): 4505.

https://doi.org/10.1182/blood-2019-131380

Published: 2019

Journal Articles

Increased Mean Corpuscular Volume Is an Independent Predictor for Worse Overall Survival in Patients with Newly Diagnosed Light Chain Amyloidosis

Abdullah S. Al Saleh, MBBS, M Hasib Sidiqi, MBBS, Eli Muchtar, MD, Angela Dispenzieri, MD, Francis K. Buadi, MB, CHB, Rahma M Warsame, MD, Martha Q. Lacy, MD, David Dingli, MD PhD, Nelson Leung, MD, Wilson I Gonsalves, MD, Taxiarchis Kourelis, MD, Prashant Kapoor, MD, Ronald S. Go, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Morie A Gertz, MD, Shaji K. Kumar, MD

Blood (2019) 134 (Supplement_1): 5532.

https://doi.org/10.1182/blood-2019-131171

Published: 2019

Journal Articles

Economic Evaluation of the Direct Oral Anticoagulants Compared to Vitamin K Antagonists in the Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Analysis from the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia

Abdullah S. Al Saleh, MD, Patrick Berrigan, David Anderson, MD, Sudeep Shivakumar, MD

Blood (2016) 128 (22): 3528.

https://doi.org/10.1182/blood.V128.22.3528.3528

Published: 2016

NARROW

Comparison of Riete and Some Scores for Predicting Cancer in Unprovoked Thrombosis

Comparison of Interobserver Agreement between the 4T and the HIT Expert Probability (HEP) Scores: We Agreed Not to Agree

Effect of ABO Mismatch and RBC Alloimmunization on the Outcomes of Patients with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplantation

Treatments and Outcomes of Newly Diagnosed Multiple Myeloma Patients > 75 Years Old: A Retrospective Analysis

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

Decreased Cardiac Ejection Fraction Is Associated with Worse Survival in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Retroperitoneal Involvement of Light Chain Amyloidosis-Case Series and Literature Review

Presence of a Measurable M-Spike before Autologous Stem Cell Transplantation Is Associated with Shorter Survival in Patients with Light Chain Amyloidosis

Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma

Increased Mean Corpuscular Volume Is an Independent Predictor for Worse Overall Survival in Patients with Newly Diagnosed Light Chain Amyloidosis

Economic Evaluation of the Direct Oral Anticoagulants Compared to Vitamin K Antagonists in the Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Analysis from the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only